12916_2020_1769_MOESM3_ESM.pdf (141.6 kB)
Download file

Additional file 3 of Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Download (141.6 kB)
journal contribution
posted on 04.11.2020, 04:30 by Till F. M. Andlauer, Jenny Link, Dorothea Martin, Malin Ryner, Christina Hermanrud, Verena Grummel, Michael Auer, Harald Hegen, Lilian Aly, Christiane Gasperi, Benjamin Knier, Bertram Müller-Myhsok, Poul Erik Hyldgaard Jensen, Finn Sellebjerg, Ingrid Kockum, Tomas Olsson, Marc Pallardy, Sebastian Spindeldreher, Florian Deisenhammer, Anna Fogdell-Hahn, Bernhard Hemmer
Additional file 3. New ADA measurements and design of the datasets for analyses. New ADA measurements in the Swedish KI and German TUM cohorts per treatment preparation and assignments of samples into the discovery and replication datasets. In the discovery and replication datasets, the first number indicates nADA and the second number bADA measurements. The distinction into negative and positive patients was made using nADA measurements.


Innovative Medicines Initiative Joint Undertaking Bundesministerium für Bildung und Forschung H2020 European Research Council Deutsche Forschungsgemeinschaft